Physician profile
Benjamin Goldberg
NPI 1518917046
$119,914.03
in general payments reported to CMS, 2019-2025
34 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $16K · 2021: $13K · 2022: $8,629 · 2023: $28K · 2024: $25K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Food and Beverage: $4,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,200.00 |
| Food and Beverage | $4,316.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $102,733.14 | 2019-2025 | Acumed, Osteomed, Montage 5cc |
| Graymont Equipment Distribution, LLC | $1,800.00 | 2019 | |
| Arthrex, INC. | $1,523.68 | 2022 | |
| Smith+Nephew, INC. | $1,511.24 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Aetos Shoulder System, Evos |
| Medwest Associates | $1,451.22 | 2020-2022 | |
| Catalyst Orthoscience | $1,428.33 | 2021-2024 | Catalyst Csr Shoulder System |
| Baxter Healthcare | $1,320.00 | 2020 | |
| Axogen | $1,257.51 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Stryker Corporation | $1,061.94 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Variax |
| Medtronic, INC. | $1,000.00 | 2023 | |
| Orthofix Medical, INC. | $812.88 | 2019-2025 | Physio-Stim |
| Djo, LLC | $640.02 | 2021-2025 | Cmf |
| Zimmer Biomet Holdings, INC. | $480.51 | 2019-2021 | |
| Ge Healthcare | $417.00 | 2022 | |
| Medacta USA, INC. | $353.59 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $281.67 | 2019 | |
| Encore Medical, Lp | $249.53 | 2019-2024 | Djo Surgical |
| Bioventus LLC | $212.47 | 2019-2020 | |
| Wright Medical Technology, INC. | $210.02 | 2019-2020 | |
| Ethicon US, LLC | $187.77 | 2019-2021 | |
| Exactech, INC. | $158.08 | 2022 | |
| Bone Support INC. | $143.67 | 2022 | |
| Depuy Synthes Sales INC. | $124.52 | 2023 | Na |
| Lightbody Medical Technologies INC | $113.53 | 2024 | |
| Integra Lifesciences Corporation | $89.15 | 2020-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Fx Shoulder Solutions, INC | $84.86 | 2023 | |
| Steris Corporation | $74.92 | 2019-2020 | |
| Innovation Technologies INC | $45.90 | 2020-2021 | |
| Biocomposites INC | $37.02 | 2019 | |
| Medartis INC. | $31.36 | 2019-2021 | |
| Skeletal Dynamics INC | $28.85 | 2021-2025 | Align, Geminus, Ijs |
| Pfizer INC. | $26.55 | 2019-2020 | |
| Conmed Corporation | $12.10 | 2019 | |
| Misonix INC | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.